Congenital adrenal hyperplasia (CAH) is a group of genetic disorders affecting the adrenal glands, which produce hormones essential for various bodily functions. One of the most common forms of ...
for use alongside glucocorticoids in managing classic congenital adrenal hyperplasia (CAH) in patients aged four and older. This marks a significant advancement for a rare genetic condition that ...
Despite the recent launch of congenital adrenal hyperplasia (CAH) drug Crenessity, Neurocrine Biosciences' disappointing ...
its experimental therapy for congenital adrenal hyperplasia (CAH). CAH, a group of genetic disorders affecting adrenal glands, is characterized by excessive levels of androstenedione (A4), a ...
The FDA has granted priority review designation for two new drug applications for a selective corticotropin-releasing factor type 1 receptor to treat congenital adrenal hyperplasia, according to a ...
Atumelnant is currently in development for congenital adrenal hyperplasia and ACTH-dependent Cushing’s syndrome. For more information about the Phase 2 TouCAHn study in classic CAH, please visit ...
Hypertension is an important public health problem affecting more than 50 million individuals in the US alone. The most common form, essential hypertension, results from the complex interplay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback